New platform optimizes drug doses to prevent organ rejection for transplant patients – Medical Xpress

UCLA scientists say the finding that every patient’s response to medical treatment produces a parabola-shaped graph, like those here, is a landmark advance. Credit: UCLA School of Dentistry For decades, doctors and scientists have predicted that personalized medicine—tailoring drug doses and combinations to people’s specific diseases and body chemistry—would be the future of health care. … Continue reading “New platform optimizes drug doses to prevent organ rejection for transplant patients – Medical Xpress”

Transplant Genomics Announces Expansion of Scientific Advisory Board – Business Wire (press release)

PLEASANTON, Calif.–(BUSINESS WIRE)–Transplant Genomics Inc. (TGI) is a molecular diagnostics company committed to improving kidney transplant outcomes through tests that support physician decisions on personalized immunosuppression. The company’s TruGraf™ blood test relies on analysis of gene expression profiles to detect molecular signatures indicative of acute rejection, differentiating this clinical phenotype from nonimmune causes of dysfunction … Continue reading “Transplant Genomics Announces Expansion of Scientific Advisory Board – Business Wire (press release)”